Clinical trial
A Phase I/II Study of Revlimid (Lenalidomide) in Combination With Vidaza (Azacitidine) in Patients With Advanced Myelodysplastic Syndrome (MDS)
NCT00352001 is registered in ClinicalTrials.gov with Mikkael Sekeres MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I/II Study of Revlimid (Lenalidomide) in Combination With Vidaza (Azacitidine) in Patients With Advanced Myelodysplastic Syndrome (MDS)
- Lead sponsor
- Mikkael Sekeres MD
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- May 31, 2006
- Completion date
- September 30, 2011
- Enrollment
- 37 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.